Hypertension in children with chronic kidney disease: pathophysiology and management
Authors:
Open Access
- 8 November 2007
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 23 (3) , 363-371
Abstract
Arterial hypertension is very common in children with all stages of chronic kidney disease (CKD). While fluid overload and activation of the renin–angiotensin system have long been recognized as crucial pathophysiological pathways, sympathetic hyperactivation, endothelial dysfunction and chronic hyperparathyroidism have more recently been identified as important factors contributing to CKD-associated hypertension. Moreover, several drugs commonly administered in CKD, such as erythropoietin, glucocorticoids and cyclosporine A, independently raise blood pressure in a dose-dependent fashion. Because of the deleterious consequences of hypertension on the progression of renal disease and cardiovascular outcomes, an active screening approach should be adapted in patients with all stages of CKD. Before one starts antihypertensive treatment, non-pharmacological options should be explored. In hemodialysis patients a low salt diet, low dialysate sodium and stricter dialysis towards dry weight can often achieve adequate blood pressure control. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers are first-line therapy for patients with proteinuria, due to their additional anti-proteinuric properties. Diuretics are a useful alternative for non-proteinuric patients or as an add-on to renin–angiotensin system blockade. Multiple drug therapy is often needed to maintain blood pressure below the 90th percentile target, but adequate blood pressure control is essential for better renal and cardiovascular long-term outcomes.Keywords
This publication has 80 references indexed in Scilit:
- Renalase, a catecholamine-metabolising enzyme?Journal of Neural Transmission, 2007
- Prescription of drugs blocking the renin-angiotensin system in Italian childrenPediatric Nephrology, 2007
- Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitorsPediatric Nephrology, 2006
- Renal and Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitor Plus Angiotensin II Receptor Antagonist Therapy in Children With ProteinuriaPediatrics, 2006
- Prevalence, Persistence, and Clinical Significance of Masked Hypertension in YouthHypertension, 2005
- GH Increases Extracellular Volume by Stimulating Sodium Reabsorption in the Distal Nephron and Preventing Pressure NatriuresisThe Journal of Clinical Endocrinology & Metabolism, 2002
- Mortality and causes of death of end-stage renal disease in children: A Dutch cohort studyKidney International, 2002
- Nitric Oxide Metabolism in Erythropoietin-Induced HypertensionHypertension, 1998
- Feasibility of a Clinic‐Based Hypocaloric Dietary Intervention Implemented in a School Setting for Obese ChildrenObesity Research, 1996
- The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese AdolescentsNew England Journal of Medicine, 1989